Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2001 Aug 28;98(18):10025–10027. doi: 10.1073/pnas.191380198

Making sense (and antisense) of the X inactivation center

Huntington F Willard 1,*, Laura Carrel 1
PMCID: PMC56906  PMID: 11526224

The concept of the X inactivation center (Xic) as the master regulatory locus for X inactivation dates back to the mid-1960s (1, 2), not long after X chromosome inactivation itself was proposed as the mammalian dosage compensation mechanism (35). Defined genetically as the cis-acting locus required for an X chromosome to undergo inactivation early in female embryogenesis, the Xic defied molecular characterization for nearly 30 years until the discovery of the XIST gene (6), whose noncoding RNA product is transcribed from and remains intimately associated with the inactive X chromosome in female somatic cells (69). Xist in both humans and mice maps to the Xic region on the X chromosome and thus became a compelling candidate for a component of the Xic itself (1012). Biology is rarely as simple as it first appears, however, and X inactivation embodies this principle fully! Only a few years ago, Lee and colleagues (13) described another component of the Xic just downstream of Xist, the Tsix gene, so-named because it consists of an antisense transcript of Xist and whose pattern of expression suggested a potential role as a regulator of Xist. Now, in this issue of PNAS, Stavropoulos et al. (14) extend these studies to address a fundamental question concerning the potential function of Tsix—does its antagonistic relationship to Xist depend on its own noncoding RNA product or does it reflect actions at the DNA level, independent of transcription?

What evidence implicates Xist or Tsix as functional components of the Xic? The process of random X inactivation consists of multiple steps, responsible for assessing the number of X chromosomes in the developing mammalian embryo (counting), designating one or the other X as the future active or inactive X chromosome (choice), initiating and promulgating this choice along the length of the inactive X chromosome in cis to silence most of the genes on that X (initiation), and stably maintaining the inactive chromatin state through subsequent cell divisions (maintenance) (reviewed in refs. 1517). [The choice step is predetermined in the imprinted form of X inactivation, in which the paternally inherited X is always the inactive X, as is seen in marsupials and in extraembryonic tissues in eutherian mammals (18).]

Transgenic experiments have demonstrated that DNA from the Xic (including Xist and Tsix sequences) can largely recapitulate X inactivation (e.g., ref. 19), and more refined targeted mutagenesis studies have implicated specific sequences in the various steps of the X inactivation pathway. Specific regions in the Xic contribute to counting and choice (e.g., refs. 20 and 21), in addition to the role of the Xist transcripts themselves in initiation of silencing on the inactive X. But what controls expression of Xist itself and determines whether it produces abundant RNA product (localized on the inactive X) or whether it is itself suppressed (on the active X)? This is where the antisense Tsix gene appears to come in.

Tsix has been proposed to be the regulatory “switch” that determines whether Xist is on or off.

Transcription of Tsix initiates principally from a promoter near a CpG island about 15 kb downstream from the 3′ terminus of Xist and extends across Xist in the antisense direction (13, 22). In differentiating female mouse embryonic stem cells, Tsix RNA (which is initially transcribed along with Xist from both X chromosomes) is turned off on one X that then accumulates Xist transcripts and becomes the inactive X (Fig. 1A). In contrast, Tsix RNA persists longer on the other X, on which Xist is then turned off, enabling it to become established as the active X. Because of this dynamic and complementary relationship, Tsix has been proposed to be the regulatory “switch” that determines whether Xist is on or off and thus whether the X becomes the inactive or active X (16, 17). This model predicts that targeted mutation of Tsix should influence Xist expression and thus the choice of whether one or the other X becomes inactive. A number of studies have tested this hypothesis directly and have implicated a 2-kb region at the 5′ end of Tsix (2224). For example, when sequences near the Tsix CpG island are deleted (ΔCpG; Fig. 1B), the targeted X expresses Xist constitutively, leading to that X being designated the inactive X in all cells (23). Although these and similar experiments indicate the involvement of these sequences in the cis regulation of Xist expression and thus in the choice step of X inactivation, the precise mechanism of their involvement has remained obscure. The question remains whether they act through DNA as a long-range silencer to repress Xist or whether it is the Tsix transcripts themselves that act to antagonize Xist in cis. Tsix RNA could function in a number of ways, either through a mechanism that prevents Xist transcription or via direct interactions between the Xist and Tsix RNAs themselves (17).

Figure 1.

Figure 1

Schematic representation of proposed events at the Xist and Tsix loci in the X inactivation center. (A) In normal female embryonic cells, both genes are expressed in the early embryo, before the onset of inactivation. Tsix is then suppressed on one X, which continues to express Xist (the future inactive X, Xi). On the other X, Tsix continues to be expressed, whereas Xist is suppressed (the future active X, Xa). As a result of the choice step of inactivation, there are two populations of cells (Left and Right), in which one or the other X is chosen to be the future Xa (or Xi). (B) In cells in which the promoter region of Tsix has been deleted (ΔCpG in ref. 23; see also refs. 21 and 22), X inactivation is nonrandom. The targeted X is the Xi in all cells, suggesting that Tsix expression and/or this region of the Tsix gene is responsible for suppressing Xist in cis. (C) In cells in which Tsix is constitutively expressed, as described in this issue (14), due to targeting at the Tsix promoter (yellow star), Tsix shows high-level expression (large blue arrow). This prevents expression of Xist from that X in both cell lineages. These data indicate that it is the Tsix RNA itself that is responsible for suppression of Xist, providing mechanistic insight into this critical early step in X inactivation.

It is this question that Lee and her colleagues (14) have addressed. They have generated a constitutive “knock-in” allele of Tsix, by targeting an active human EF1a promoter into one Tsix allele in female mouse embryonic stem cells. Upon differentiation, the persistent high-level expression of Tsix transcripts from this allele is sufficient to block the usual accumulation of Xist transcripts on that X chromosome, thus preventing it from becoming an inactive X (Fig. 1C). [In cells in which the other (nontargeted) X is chosen and the normal Tsix allele is shut off, Xist expression continues unperturbed only on that X, and X inactivation proceeds normally.] This effect of persistent high-level Tsix expression seems likely to be caused by the transcripts themselves, because the targeting event doesn't remove any Tsix sequences, although indirect effects on chromatin caused by the knock-in are difficult to exclude completely.

The story doesn't end there, however. The earlier Tsix knockout mutations led to nonrandom inactivation of the mutated X chromosome, providing critical evidence that Tsix was required to silence the Xist allele on the same X (21, 23). Without Tsix, Xist expression continued unabated, thus ensuring that that X chromosome would be the inactive X in all cells (Fig. 1B). By comparison, then, one might have predicted that the constitutive Tsix allele reported (14) would result in complete nonrandom inactivation of the nonmutated X, secondary to the constitutive active state of the mutated X necessitated by persistent Tsix expression. However, this was not the case. In fact, choice appears not to have been affected by this targeted mutation. At the expected frequency, in some cells, the nonmutated X was chosen to be the inactive X, and X inactivation proceeded normally. But the remaining cells, in which the mutated X would be predicted to be chosen to be the inactive X, in fact show no X inactivation at all (Fig. 1C). In these cells, persistent high-level Tsix expression is apparently epistatic to X inactivation, and the steps of the X inactivation pathway downstream of choice are blocked. This result establishes that Tsix transcripts have a functional role in random X inactivation, suppressing Xist, and that shutting off of Tsix expression is a necessary step to permit inactivation of that X. These data support and complement data indicating a role for Tsix in imprinted X inactivation as well (22, 25).

So, does the Xic consist of just these two interacting genes, the sense Xist gene and its antisense antagonist Tsix? Again, the story is not apt to be that simple. At a minimum, there are additional sequences yet further downstream of Xist (i.e., upstream of Tsix) that appear to be involved in X inactivation. The X controlling element locus, Xce, of Cattanach has been defined genetically (26) and maps at least 40 kb away from the Xist 3′ end or the Tsix promoter (27). Xce influences the choice step of X inactivation, and mice heterozygous for variants at this locus show a nonrandom pattern of inactivation that reflects the relative strength of different Xce alleles (26). Although the molecular nature of Xce has not been determined, targeted deletion and add-back studies have implicated sequences in this vicinity in counting or choice, independent of Tsix transcription (22, 28). Whether these constitute the Xce locus has not been established. Further, whether they represent long-range regulatory sites for either Tsix or Xist and, if so, what their trans-acting binding partners might be remains unknown. Further, as X inactivation exists in both an imprinted and nonimprinted (i.e., random) form, it is conceivable that regulatory sites within the Xic differ between the two.

A long-standing model for X inactivation has posited a trans-acting, autosomally encoded “blocking factor” that interacts with sequences in the Xic to designate the future active X, thus allowing the other X (or all remaining Xs in the case of aneuploid cells) to be inactivated (29, 30). The paper reported in this issue (14), together with other recent studies (22, 23, 28), begin to delimit the location of possible binding sites within the Xic for such a blocking factor. The factor could be a protein involved directly in the regulation of Tsix or less directly in binding to the Xce sequences located upstream of Tsix.

Tsix “on?” No Xist! Whichever direction you read it, Xist and Tsix both appear to be critical components of the Xic and the X inactivation pathway. Although the cis interactions within the Xic and between the Xic and the X chromosome itself are becoming clearer, it remains to define the thus far elusive trans-acting factors that set this cascade in motion in the first place. Only then will we be able to claim to make sense (or antisense) of this complex developmental and chromosomal phenomenon.

Footnotes

See companion article on page 10232.

References

  • 1.Lyon M F. Second International Conference on Congenital Malforrmations. New York: International Medical Congress; 1963. pp. 67–68. [Google Scholar]
  • 2.Russell L B, Montgomery C S. Genetics. 1965;52:470–471. [Google Scholar]
  • 3.Lyon M F. Nature (London) 1961;190:372–373. doi: 10.1038/190372a0. [DOI] [PubMed] [Google Scholar]
  • 4.Russell L B. Science. 1961;133:1795–1803. doi: 10.1126/science.133.3467.1795. [DOI] [PubMed] [Google Scholar]
  • 5.Beutler E, Yeh M, Fairbanks V F. Proc Natl Acad Sci USA. 1962;48:9–16. doi: 10.1073/pnas.48.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Brown C J, Ballabio A, Rupert J L, Lafreniere R G, Grompe M, Tonlorenzi R, Willard H F. Nature (London) 1991;349:38–44. doi: 10.1038/349038a0. [DOI] [PubMed] [Google Scholar]
  • 7.Brockdorff N, Ashworth A, Kay G F, McCabe V M, Norris D P, Cooper P J, Swift S, Rastan S. Cell. 1992;71:515–526. doi: 10.1016/0092-8674(92)90519-i. [DOI] [PubMed] [Google Scholar]
  • 8.Brown C J, Hendrich B D, Rupert J L, Lafreniere R G, Xing Y, Lawrence J, Willard H F. Cell. 1992;71:527–542. doi: 10.1016/0092-8674(92)90520-m. [DOI] [PubMed] [Google Scholar]
  • 9.Clemson C M, McNeil J A, Willard H F, Lawrence J B. J Cell Biol. 1996;132:1–17. doi: 10.1083/jcb.132.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Brown C J, Lafreniere R G, Powers V E, Sebastio G, Ballabio A, Pettigrew A L, Ledbetter D H, Levy E, Craig I W, Willard H F. Nature (London) 1991;349:82–84. doi: 10.1038/349082a0. [DOI] [PubMed] [Google Scholar]
  • 11.Borsani G, Tonlorenzi R, Simmler M C, Dandolo L, Arnaud D, Capra V, Grompe M, Pizzuti A, Muzny D, Lawrence C, et al. Nature (London) 1991;351:325–329. doi: 10.1038/351325a0. [DOI] [PubMed] [Google Scholar]
  • 12.Brockdorff N, Ashworth A, Kay G F, Cooper P, Smith S, McCabe V M, Norris D P, Penny G D, Patel D, Rastan S. Nature (London) 1991;351:329–331. doi: 10.1038/351329a0. [DOI] [PubMed] [Google Scholar]
  • 13.Lee J T, Davidow L S, Warshawsky D. Nat Genet. 1999;21:400–404. doi: 10.1038/7734. [DOI] [PubMed] [Google Scholar]
  • 14.Stavropoulos N, Lu N, Lee J T. Proc Natl Acad Sci USA. 2001;98:10232–10237. doi: 10.1073/pnas.171243598. . (First Published July 31, 2001; 10.1073/pnas.171243598) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Heard E, Clerc P, Avner P. Annu Rev Genet. 1997;31:571–610. doi: 10.1146/annurev.genet.31.1.571. [DOI] [PubMed] [Google Scholar]
  • 16.Avner P, Heard E. Nat Rev Genet. 2001;2:59–67. doi: 10.1038/35047580. [DOI] [PubMed] [Google Scholar]
  • 17.Boumil, R. M. & Lee, J. T. (2001) Hum. Mol. Genet., in press. [DOI] [PubMed]
  • 18.Takagi N, Sasaki M. Nature (London) 1975;256:640–642. doi: 10.1038/256640a0. [DOI] [PubMed] [Google Scholar]
  • 19.Lee J T, Lu N, Han Y. Proc Natl Acad Sci USA. 1999;96:3836–3841. doi: 10.1073/pnas.96.7.3836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Penny G D, Kay G F, Sheardown S A, Rastan S, Brockdorff N. Nature (London) 1996;379:131–137. doi: 10.1038/379131a0. [DOI] [PubMed] [Google Scholar]
  • 21.Clerc P, Avner P. Nat Genet. 1998;19:249–253. doi: 10.1038/924. [DOI] [PubMed] [Google Scholar]
  • 22.Sado T, Wang Z, Sasaki H, Li E. Development (Cambridge, UK) 2001;128:1275–1286. doi: 10.1242/dev.128.8.1275. [DOI] [PubMed] [Google Scholar]
  • 23.Lee J T, Lu N. Cell. 1999;99:47–57. doi: 10.1016/s0092-8674(00)80061-6. [DOI] [PubMed] [Google Scholar]
  • 24.Debrand E, Chureau C, Arnaud D, Avner P, Heard E. Mol Cell Biol. 1999;19:8513–8525. doi: 10.1128/mcb.19.12.8513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lee J T. Cell. 2000;103:17–27. doi: 10.1016/s0092-8674(00)00101-x. [DOI] [PubMed] [Google Scholar]
  • 26.Cattanach B M. Genet Res. 1970;16:293–301. doi: 10.1017/s001667230000255x. [DOI] [PubMed] [Google Scholar]
  • 27.Simmler M-C, Cattanach B, Rasberry C, Rougeulle C, Avner P. Mamm Genome. 1993;4:523–530. doi: 10.1007/BF00364788. [DOI] [PubMed] [Google Scholar]
  • 28.Morey C, Arnaud D, Avner P, Clerc P. Hum Mol Genet. 2001;10:1403–1411. doi: 10.1093/hmg/10.13.1403. [DOI] [PubMed] [Google Scholar]
  • 29.Lyon M F. Nat New Biol. 1971;232:229–232. doi: 10.1038/newbio232229a0. [DOI] [PubMed] [Google Scholar]
  • 30.Brown S W, Chandra H S. Proc Natl Acad Sci USA. 1973;70:195–199. doi: 10.1073/pnas.70.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES